These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


315 related items for PubMed ID: 19533356

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia.
    Moawad FJ, Veerappan GR, Dias JA, Baker TP, Maydonovitch CL, Wong RK.
    Am J Gastroenterol; 2013 Mar; 108(3):366-72. PubMed ID: 23399553
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis.
    Noel RJ, Putnam PE, Collins MH, Assa'ad AH, Guajardo JR, Jameson SC, Rothenberg ME.
    Clin Gastroenterol Hepatol; 2004 Jul; 2(7):568-75. PubMed ID: 15224281
    [Abstract] [Full Text] [Related]

  • 6. Eosinophilic esophagitis: a 10-year experience in 381 children.
    Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, Semeao E, Flick J, Kelly J, Brown-Whitehorn T, Mamula P, Markowitz JE.
    Clin Gastroenterol Hepatol; 2005 Dec; 3(12):1198-206. PubMed ID: 16361045
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oral delivery of fluticasone powder improves esophageal eosinophilic inflammation and symptoms in adults with eosinophilic esophagitis.
    Kia L, Nelson M, Zalewski A, Gregory D, Gonsalves N, Straumann A, Hirano I.
    Dis Esophagus; 2018 Dec 01; 31(12):. PubMed ID: 30380044
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Non-surgical interventions for eosinophilic esophagitis.
    Elliott EJ, Thomas D, Markowitz JE.
    Cochrane Database Syst Rev; 2010 Mar 17; 2010(3):CD004065. PubMed ID: 20238328
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis.
    Lucendo AJ, De Rezende LC, Jiménez-Contreras S, Yagüe-Compadre JL, González-Cervera J, Mota-Huertas T, Guagnozzi D, Angueira T, González-Castillo S, Arias A.
    Dig Dis Sci; 2011 Dec 17; 56(12):3551-8. PubMed ID: 21674173
    [Abstract] [Full Text] [Related]

  • 15. Serum eosinophil cationic protein is superior to mast cell tryptase as marker for response to topical corticosteroid therapy in eosinophilic esophagitis.
    Schlag C, Pfefferkorn S, Brockow K, Haller B, Slotta-Huspenia J, Schulz S, von Werder A, Ring J, Schmid RM, Bajbouj M.
    J Clin Gastroenterol; 2014 Aug 17; 48(7):600-6. PubMed ID: 24177377
    [Abstract] [Full Text] [Related]

  • 16. 3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults.
    Helou EF, Simonson J, Arora AS.
    Am J Gastroenterol; 2008 Sep 17; 103(9):2194-9. PubMed ID: 18637093
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prospective, comparative effectiveness trial of cow's milk elimination and swallowed fluticasone for pediatric eosinophilic esophagitis.
    Kruszewski PG, Russo JM, Franciosi JP, Varni JW, Platts-Mills TA, Erwin EA.
    Dis Esophagus; 2016 May 17; 29(4):377-84. PubMed ID: 25721813
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment outcomes for eosinophilic esophagitis in children with esophageal atresia.
    Chan LJ, Tan L, Dhaliwal J, Briglia F, Clarkson C, Krishnan U.
    Dis Esophagus; 2016 Aug 17; 29(6):563-71. PubMed ID: 25872589
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.